Retrospective Study
Copyright ©The Author(s) 2023.
World J Clin Cases. Jan 26, 2023; 11(3): 556-565
Published online Jan 26, 2023. doi: 10.12998/wjcc.v11.i3.556
Table 4 Comparison of calcitonin gene-related peptide, ubiquitin carboxyl-terminal hydrolase 1, tumor necrosis factor-α, interleukin-2, interleukin-8 between and within groups (mean ± SD)
Indicators
Time
Control group (n = 34)
Observation group (n = 34)
t value
P value
CGRP (pg/mL)Before treatment21.52 ± 5.3620.97 ± 5.710.4090.683
After treatment28.26 ± 6.17a36.58 ± 6.78a5.2920.000
UCH-L1 (µg/L)Before treatment0.40 ± 0.180.41 ± 0.130.2630.794
After treatment0.25 ± 0.11a0.17 ± 0.10a3.1380.003
TNF-α (pg/mL)Before treatment44.52 ± 5.8942.97 ± 6.011.0740.287
After treatment21.02 ± 4.15a14.63 ± 3.85a6.5820.000
IL-2 (pg/mL)Before treatment15.89 ± 2.1615.81 ± 2.240.1500.881
After treatment10.13 ± 1.92a6.78 ± 1.52a7.9770.000
IL-8 (pg/mL)Before treatment5.23 ± 0.825.18 ± 0.910.2380.813
After treatment4.64 ± 0.53a3.47 ± 0.42a10.0880.000